Acadian Asset Management
HZNP

Acadian Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Acadian Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,617
Closed -$149K – 2328
2021
Q1 		$149K Sell
1,617
-311,851
-99% -$26.3M ﹤0.01% 1576
2020
Q4 		$22.9M Sell
313,468
-7,465
-2% -$555K 0.09% 194
2020
Q3 		$24.9M Sell
320,933
-18,955
-6% -$1.3M 0.1% 178
2020
Q2 		$18.9M Sell
339,888
-8,790
-3% -$376K 0.08% 221
2020
Q1 		$10.3M Sell
348,678
-122,181
-26% -$4.13M 0.06% 253
2019
Q4 		$17M Sell
470,859
-330,592
-41% -$10.1M 0.08% 223
2019
Q3 		$21.8M Buy
801,451
+39,194
+5% +$1.01M 0.09% 199
2019
Q2 		$18.3M Buy
762,257
+140,309
+23% +$3.56M 0.09% 200
2019
Q1 		$16.4M Buy
621,948
+296,762
+91% +$7.03M 0.07% 216
2018
Q4 		$6.35M Buy
325,186
+161,738
+99% +$3.17M 0.03% 340
2018
Q3 		$3.2M Buy
+163,448
New +$3.11M 0.01% 459
2017
Q4 		– Sell
-496
Closed -$6K – 1742
2017
Q3 		$6K Buy
+496
New +$6.31K ﹤0.01% 1330
2017
Q2 		– Sell
-377
Closed -$6K – 1704
2017
Q1 		$6K Sell
377
-22,000
-98% -$356K ﹤0.01% 1477
2016
Q4 		$363K Buy
22,377
+17,910
+401% +$325K ﹤0.01% 928
2016
Q3 		$80K Buy
4,467
+3,843
+616% +$75.1K ﹤0.01% 1093
2016
Q2 		$11K Buy
624
+44
+8% +$712 ﹤0.01% 1221
2016
Q1 		$10K Buy
+580
New +$10.1K ﹤0.01% 1201

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Acadian Asset Management's HZNP Position: Q2 2021 in Review

Acadian Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 1,617 shares — an estimated $149K sold.

Acadian Asset Management first reported a position in HZNP in Q1 2016 and held it in 17 quarters. The position peaked at $24.9M in Q3 2020. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

  • Acadian Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Acadian Asset Management sold 1,617 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $149K.
  • Acadian Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016 and held it in 17 quarters.
  • Acadian Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $24.9M in Q3 2020.
  • 526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on Acadian Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.